Clinical safety and efficacy of the first-in-class Rho kinase inhibitor for lowering IOP: netarsudil and the fixed-dose combination of netarsudil and latanoprost €15.00 Clinical safety and efficacy of the first-in-class Rho kinase inhibitor for lowering IOP: netarsudil and the fixed-dose combination of netarsudil and latanoprost quantity Add to cart Category: Articles Tag: Volume 3 Description Description Authors: Janet B. Serle, Jake Radell Related products The multiple-hit theory on the pathogenesis of primary open-angle glaucoma €15.00 Add to cart Structure-function relationships in the optic nerve head and the consequences of regional pressure disturbances €15.00 Add to cart The interleukin-20 (IL-20) story €15.00 Add to cart Intraocular pressure control through linked trabecular meshwork and collector channel motion €15.00 Add to cart